Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer

Michael A. Choti, Michele Thomas, Schiffon L. Wong, Michael Eaddy, Timothy M. Pawlik, Kenzo Hirose, Matthew J. Weiss, Jonathan Kish, Mark R. Green

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background: Liver resection is a key therapeutic strategy to improve survival in patients with colorectal cancer liver metastases. Underutilization may negatively affect outcomes. Using a Web-based survey and standardized imaging scenarios, this study assessed medical oncologists’ (MOs) perceptions of resectability, preferences for chemotherapy sequencing, and referral for surgical consultation in a static patient profile of good performance status and no extrahepatic spread but varying bulk and distribution of disease. Methods: A total of 190 US-based MOs were surveyed. A single patient profile was created and combined with 10 different sets of liver computed tomographic images displaying a broad spectrum of metastases. Assessments of resectability and ranking were compared with the results obtained from an expert panel of 3 hepatic surgeons. Results: The expert hepatic surgeons designated 8 scans resectable, 1 borderline resectable/convertible, and 1 unresectable. In the 8 resectable cases, 34.4 % of MOS perceived the case to be initially resectable, 41.7 % potentially resectable after chemotherapy response, and 23.9 % unresectable. Increasing number of lesions, larger tumor diameter, and bilateral disease were associated with lower resectability perception (P 

Original languageEnglish (US)
Pages (from-to)375-381
Number of pages7
JournalAnnals of Surgical Oncology
Volume23
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Colorectal Neoplasms
Neoplasm Metastasis
Liver
Drug Therapy
Liver Neoplasms
Referral and Consultation
Survival
Oncologists
Neoplasms
Surgeons
Therapeutics

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer. / Choti, Michael A.; Thomas, Michele; Wong, Schiffon L.; Eaddy, Michael; Pawlik, Timothy M.; Hirose, Kenzo; Weiss, Matthew J.; Kish, Jonathan; Green, Mark R.

In: Annals of Surgical Oncology, Vol. 23, No. 2, 01.02.2016, p. 375-381.

Research output: Contribution to journalArticle

Choti, Michael A. ; Thomas, Michele ; Wong, Schiffon L. ; Eaddy, Michael ; Pawlik, Timothy M. ; Hirose, Kenzo ; Weiss, Matthew J. ; Kish, Jonathan ; Green, Mark R. / Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer. In: Annals of Surgical Oncology. 2016 ; Vol. 23, No. 2. pp. 375-381.
@article{01116aa8104c45d283d26b193eb69a3d,
title = "Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer",
abstract = "Background: Liver resection is a key therapeutic strategy to improve survival in patients with colorectal cancer liver metastases. Underutilization may negatively affect outcomes. Using a Web-based survey and standardized imaging scenarios, this study assessed medical oncologists’ (MOs) perceptions of resectability, preferences for chemotherapy sequencing, and referral for surgical consultation in a static patient profile of good performance status and no extrahepatic spread but varying bulk and distribution of disease. Methods: A total of 190 US-based MOs were surveyed. A single patient profile was created and combined with 10 different sets of liver computed tomographic images displaying a broad spectrum of metastases. Assessments of resectability and ranking were compared with the results obtained from an expert panel of 3 hepatic surgeons. Results: The expert hepatic surgeons designated 8 scans resectable, 1 borderline resectable/convertible, and 1 unresectable. In the 8 resectable cases, 34.4 {\%} of MOS perceived the case to be initially resectable, 41.7 {\%} potentially resectable after chemotherapy response, and 23.9 {\%} unresectable. Increasing number of lesions, larger tumor diameter, and bilateral disease were associated with lower resectability perception (P ",
author = "Choti, {Michael A.} and Michele Thomas and Wong, {Schiffon L.} and Michael Eaddy and Pawlik, {Timothy M.} and Kenzo Hirose and Weiss, {Matthew J.} and Jonathan Kish and Green, {Mark R.}",
year = "2016",
month = "2",
day = "1",
doi = "10.1245/s10434-015-4925-1",
language = "English (US)",
volume = "23",
pages = "375--381",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer

AU - Choti, Michael A.

AU - Thomas, Michele

AU - Wong, Schiffon L.

AU - Eaddy, Michael

AU - Pawlik, Timothy M.

AU - Hirose, Kenzo

AU - Weiss, Matthew J.

AU - Kish, Jonathan

AU - Green, Mark R.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Background: Liver resection is a key therapeutic strategy to improve survival in patients with colorectal cancer liver metastases. Underutilization may negatively affect outcomes. Using a Web-based survey and standardized imaging scenarios, this study assessed medical oncologists’ (MOs) perceptions of resectability, preferences for chemotherapy sequencing, and referral for surgical consultation in a static patient profile of good performance status and no extrahepatic spread but varying bulk and distribution of disease. Methods: A total of 190 US-based MOs were surveyed. A single patient profile was created and combined with 10 different sets of liver computed tomographic images displaying a broad spectrum of metastases. Assessments of resectability and ranking were compared with the results obtained from an expert panel of 3 hepatic surgeons. Results: The expert hepatic surgeons designated 8 scans resectable, 1 borderline resectable/convertible, and 1 unresectable. In the 8 resectable cases, 34.4 % of MOS perceived the case to be initially resectable, 41.7 % potentially resectable after chemotherapy response, and 23.9 % unresectable. Increasing number of lesions, larger tumor diameter, and bilateral disease were associated with lower resectability perception (P 

AB - Background: Liver resection is a key therapeutic strategy to improve survival in patients with colorectal cancer liver metastases. Underutilization may negatively affect outcomes. Using a Web-based survey and standardized imaging scenarios, this study assessed medical oncologists’ (MOs) perceptions of resectability, preferences for chemotherapy sequencing, and referral for surgical consultation in a static patient profile of good performance status and no extrahepatic spread but varying bulk and distribution of disease. Methods: A total of 190 US-based MOs were surveyed. A single patient profile was created and combined with 10 different sets of liver computed tomographic images displaying a broad spectrum of metastases. Assessments of resectability and ranking were compared with the results obtained from an expert panel of 3 hepatic surgeons. Results: The expert hepatic surgeons designated 8 scans resectable, 1 borderline resectable/convertible, and 1 unresectable. In the 8 resectable cases, 34.4 % of MOS perceived the case to be initially resectable, 41.7 % potentially resectable after chemotherapy response, and 23.9 % unresectable. Increasing number of lesions, larger tumor diameter, and bilateral disease were associated with lower resectability perception (P 

UR - http://www.scopus.com/inward/record.url?scp=84958171131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958171131&partnerID=8YFLogxK

U2 - 10.1245/s10434-015-4925-1

DO - 10.1245/s10434-015-4925-1

M3 - Article

C2 - 26561404

AN - SCOPUS:84958171131

VL - 23

SP - 375

EP - 381

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 2

ER -